4-methoxyamphetamine has been researched along with zidovudine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eiden, LE; Heyes, MP; Murray, EA; Rausch, DM | 1 |
| De Gruttola, V; Fischl, MA; Tsiatis, A; Wulfsohn, M | 1 |
1 trial(s) available for 4-methoxyamphetamine and zidovudine
| Article | Year |
|---|---|
Modeling the relationship between survival and CD4 lymphocytes in patients with AIDS and AIDS-related complex.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; CD4-Positive T-Lymphocytes; Death; Double-Blind Method; Humans; Leukocyte Count; Placebos; Zidovudine | 1993 |
1 other study(ies) available for 4-methoxyamphetamine and zidovudine
| Article | Year |
|---|---|
Zidovudine treatment prolongs survival and decreases virus load in the central nervous system of rhesus macaques infected perinatally with simian immunodeficiency virus.
Topics: Animals; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Central Nervous System; Cerebrospinal Fluid; Death; Female; Macaca mulatta; Male; Motor Activity; Quinolinic Acid; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Time Factors; Viral Core Proteins; Zidovudine | 1995 |